Patent · US Active

Nucleic acids encoding interleukin-31 monoclonal antibody and uses thereof

US9206253B2 · kind B2 · utility

8Cited by
2References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 8, 2014
Grant dateDec 8, 2015
Priority date
Expiry dateJul 8, 2034

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/54
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An isolated antibody that specifically binds to at least one of canine Interleukin-31 (IL-31) or feline IL-31 is provided. Such antibodies can be in the form of diagnostic and/or veterinary compositions useful for treating a pruritic and/or allergic condition in dogs or cats.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.